Core Scientific Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? Core Scientific Inc trades at $15.61 (market cap $5.12B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 4.9× Core Scientific Inc's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Core Scientific Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Core Scientific Inc for 20 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| CORZ | ROIV | |
|---|---|---|
Market Cap | $5.12B | $25.09B |
Volume | 9,296,664 | 5,738,571 |
Sector | Technology | Health |
52-Week High | $29.16 | $41.81 |
52-Week Low | $13.57 | $16.04 |
Typical Hold Time | 20 Days | 0 Days |
Enterprise Value | $7.65B | $21.36B |
Signals from Pluang's Aura AI — not financial advice
Core Scientific (CORZ) trades at $15.94, down 4.44% today amid bearish technical signals. The stock shows weak fundamentals with a -324.9% net income margin and negative earnings misses in recent quarters. However, analyst sentiment remains overwhelmingly positive with 86% buy ratings and a $32.46 consensus price target. Recent executive appointments and AI data center expansion plans provide growth catalysts despite current profitability challenges.
The outlook balances strong analyst conviction against fundamental weakness. While the AI infrastructure pivot offers long-term potential, investors face significant execution risks and negative cash flow. The stock trades near support levels with technical indicators suggesting caution, requiring careful monitoring of revenue growth and margin improvement for sustained recovery.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →